SEC Form 4 · accession 0001209191-15-069778
AVANOS MEDICAL, INC. · AVNS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert E Abernathy
Officer — Chairman and CEO · Director
Period of report
Sep 4, 2015
Accepted (ET)
Sep 8, 2015 · 3:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001606498
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 4, 2015 | P | 10,000 | $31.06 | A | 80,043 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person bought 10,000 shares at a weighted-average purchase price of $31.06, with prices ranging from $30.89 to $31.22. Upon request and as required, the reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, more information regarding the number of shares purchased at each separate price within the range set forth herein.